Navigation Links
Angiotech announces market launch of Quill(TM) SRS MONODERM(TM)
Date:6/13/2008

VANCOUVER, June 13 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, today announced the market launch of Quill(TM) SRS MONODERM(TM). The product will be available immediately for distribution and sale in the U.S. and Europe.

Quill(TM) SRS MONODERM(TM), which is made from a rapidly resorbing polymer, is intended primarily for superficial wound closure applications and indicated for soft tissue approximation where use of an absorbable suture is appropriate.

"The launch of MONODERM(TM) is another example of the progress we have made in expanding the Quill(TM) SRS product line," said Dr. William Hunter, President and CEO of Angiotech. "MONODERM(TM) is intended primarily for skin closure and will complement Quill(TM) SRS which currently targets deeper layers of wound closure."

Forward Looking Statements

--------------------------

Statements contained in this press release that are not based on historical fact, including without limitation statements containing the words "believes," "may," "plans," "will," "estimate," "continue," "anticipates," "intends," "expects" and similar expressions, constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and constitute "forward-looking information" within the meaning of applicable Canadian securities laws. All such statements are made pursuant to the "safe harbor" provisions of applicable securities legislation. Forward-looking statements may involve, but are not limited to, comments with respect to our strategies or future actions, our targets, expectations for our financial condition and the results of, or outl
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Angiotechs corporate partner, Cook Medical, announces positive interim results for its Zilver(R) PTX(TM) clinical study
2. Angiotech announces completion of Bio-Seal(TM) clinical trial enrolment
3. Angiotech appoints Hank McKinnell to its Board of Directors
4. Angiotech to participate in Bank of America Health Care Conference
5. Angiotech Expands Quill(TM) SRS product offering receiving FDA 510(k) approval for smaller size diameters of Quill(TM) SRS PDO
6. Angiotech elects to suspend Vascular Wrap(TM) pivotal clinical trials
7. Angiotechs Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System
8. Angiotechs novel 5-FU Central Venous Catheter receives FDA 510(k) clearance
9. Angiotech announces director resignation
10. Angiotech announces commercial launch of Cook Medicals Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand
11. Angiotech to participate in Credit Suisse Global Leveraged Finance Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...G, Nov. 25 /PRNewswire-Asia/ -- Sinovac Biotech Lt...cines, announced today that it executed,a joint ve... Vaccine,Technology Co., Ltd. (Sinovac Dalian). Th...lize human-use vaccines. Sinovac will contribute i...ercializing world-class vaccines; the,other party ...
(Date:11/25/2009)...25 Ardea Biosciences, In...Quart, Pharm.D., president and chief executive off...l Health Care Conference. , ,Presentation details... Care Conference,Date: Tuesday, December 1, 2...he New York Palace Hotel, New York, NY,Webcast: ...
(Date:11/24/2009)... 24 IES (Nasdaq: IESC )...mmunications systems and services for the commerci...today that its commercial business group has been ...tall the electrical systems for the Level 4 bio-sa...Army Medical Research Institute of Infectious Dise...
(Date:11/24/2009)... New York investment bank KTA Capital,s client Neu...$6.7 mil convertible note private placement with a...t was arranged by KTA Capital as Neuren,s exclusiv... New York (PRWEB) November 23, 2009 -- The ...LLC ("KTA Capital") has announced that i...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
... second in a series of articles on developing star...realm. The first edition of Early Stage focused ...adison, Wis. - So now that you know you have a pa... either one of which could be branded, what,s next...iscuss how you pick your business name. In today,s...
...an elevator next to a venture capitalist who could... the first thing about it yet. , ,You have 90 sec...se of the Elevator Pitch Olympics, a yearly event ...r, a panel of eight investors dished out advice an...resented their businesses in front of an audience....
...are signs the United States economy is cooling off... the third quarter is not one of them, according t...ists invested $6.2 billion in 797 deals during the... in both categories, according to a MoneyTree Rep... Venture Capital Association based on data from ...
Other Biology Technology:Early Stage Step 2: Choosing a domain name 2Early Stage Step 2: Choosing a domain name 3Early Stage Step 2: Choosing a domain name 49 tips for making 90 seconds count in an investment pitch 2Venture capital above $6B for third straight quarter 2Venture capital above $6B for third straight quarter 3
(Date:11/26/2009)...rized for their impressive antlers, red deer have .... But a deer,s antlers are much more than decorati...her when duelling. John Currey, from The Universit...l properties of bone for over half a century and h...of antler through a long-standing collaboration wi...
(Date:11/26/2009)... survey carried out in eight European countries ha...fectious disease pandemic could have a significant...s writing in the open access journal BMC Infectio...on school days and weekends/holidays, finding that... Hens, from Hasselt and Antwerp University, Belgiu...
(Date:11/26/2009)..., Heidelberg, 27 November 2009 What are the bare... required to produce a cell that can survive on it...cell, and understand how an entire organism functi...ons that scientists in a partnership between the E...delberg, Germany, and the Centre de Regulacio Genm...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2School closure could reduce swine flu transmission by 21 percent 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Couples Dash Around Manhattan in Search of a Diamond 26 More While Raising Money for The Leukemia 26 Lymphoma Society 57204 1Couples Dash Around Manhattan in Search of a Diamond 26 More While Raising Money for The Leukemia 26 Lymphoma Society 57204 2Couples Dash Around Manhattan in Search of a Diamond 26 More While Raising Money for The Leukemia 26 Lymphoma Society 57204 3Neuronascent to Present at Life Sciences Summit 2009 14061 1Neuronascent to Present at Life Sciences Summit 2009 14061 2Mars Veterinary Offers New Insights Into Mixed Breed Dogs 57197 1Mars Veterinary Offers New Insights Into Mixed Breed Dogs 57197 2Mars Veterinary Offers New Insights Into Mixed Breed Dogs 57197 3
...ators at the University of Rochester Medical Cente...ers a ray of hope for children with Batten disease...emingly healthy kids, progressively robs them of t...tely kills them in their young twenties. , The st...ental Neurology, explains how investigators improv...
...TOWN, Mass., Dec. 12, 2007 -- The National Science...on Gladden 1859 Professor of Biology, and Dwight W...College, a grant in the amount of $105,110. The gr... at Williams College for the study of ultra fast b...sciences. , The project builds on research transf...
... processes, such as when to multiply, are often re... timing of interactions between proteins. North Ca... the way in which a specific protein-protein inter...witches off, leading to uncontrolled cell prolifer...er published in the December 2007 edition of the C...
Other Biology News:Research unveils new hope for deadly childhood disease 2NSF awards Williams funding for high-speed imaging faciltity 2Why the switch stays on 2Why the switch stays on 3
Rabbit Anti-Human SNAPAP Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
HiTrap NHS-activated HP from GE Healthcare, formerly Amersham Biosciences
Goat Anti-Human Serpin A8 Polyclonal Antibody, Unconjugated from R&D Systems
Goat Anti-Human CXCL14 / BRAK Polyclonal Antibody, Unconjugated from R&D Systems
Biology Products: